Molecular Partners AG (MOLN)
3.72
-0.16
(-4.12%)
USD |
NASDAQ |
Jun 10, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
Molecular Partners Market Cap : 139.54M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 09, 2026 | 145.54M |
| June 08, 2026 | 148.17M |
| June 05, 2026 | 153.79M |
| June 04, 2026 | 147.42M |
| June 03, 2026 | 151.17M |
| June 02, 2026 | 147.04M |
| June 01, 2026 | 148.17M |
| May 29, 2026 | 157.54M |
| May 28, 2026 | 150.15M |
| May 27, 2026 | 151.55M |
| May 26, 2026 | 151.92M |
| May 22, 2026 | 156.80M |
| May 21, 2026 | 142.54M |
| May 20, 2026 | 140.29M |
| May 19, 2026 | 140.29M |
| May 18, 2026 | 142.54M |
| May 15, 2026 | 144.04M |
| May 14, 2026 | 144.04M |
| May 13, 2026 | 150.04M |
| May 12, 2026 | 151.55M |
| May 11, 2026 | 154.92M |
| May 08, 2026 | 153.80M |
| May 07, 2026 | 153.80M |
| May 06, 2026 | 160.32M |
| May 05, 2026 | 159.00M |
| Date | Value |
|---|---|
| May 04, 2026 | 164.86M |
| May 01, 2026 | 158.63M |
| April 30, 2026 | 158.25M |
| April 29, 2026 | 166.48M |
| April 28, 2026 | 160.12M |
| April 27, 2026 | 162.74M |
| April 24, 2026 | 166.85M |
| April 23, 2026 | 164.61M |
| April 22, 2026 | 162.37M |
| April 21, 2026 | 162.74M |
| April 20, 2026 | 164.99M |
| April 17, 2026 | 157.32M |
| April 16, 2026 | 156.38M |
| April 15, 2026 | 157.13M |
| April 14, 2026 | 154.88M |
| April 13, 2026 | 157.50M |
| April 10, 2026 | 162.07M |
| April 09, 2026 | 162.07M |
| April 08, 2026 | 158.63M |
| April 07, 2026 | 144.78M |
| April 06, 2026 | 151.14M |
| April 02, 2026 | 144.04M |
| April 01, 2026 | 149.83M |
| March 31, 2026 | 148.49M |
| March 30, 2026 | 147.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kuros Biosciences Ltd. | 9.378M |
| BeOne Medicines Ltd. | 26.94B |
| AC Immune SA | 214.68M |
| CRISPR Therapeutics AG | 4.766B |
| Idorsia Ltd. | 1.442B |
Market Cap Related Metrics
| Price to Book Value | 1.638 |
| Price | 3.72 |
| Earnings Yield | -51.76% |